Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190)
Hong Kong
· Delayed Price · Currency is HKD 19.04
+0.38 (2.04%)
May 30, 2025, 4:08 PM HKT
HKG:2190 Revenue
In the year 2024, Zylox-Tonbridge Medical Technology had annual revenue of 782.48M CNY with 48.27% growth. Zylox-Tonbridge Medical Technology had revenue of 416.49M in the half year ending December 31, 2024, with 129.66% growth.
Revenue
782.48M CNY
Revenue Growth
+48.27%
P/S Ratio
7.28
Revenue / Employee
894.26K CNY
Employees
875
Market Cap
6.06B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 32.53B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Innovent Biologics | 10.03B |
| CSPC Pharmaceutical Group | 28.99B |
| Sino Biopharmaceutical | 30.72B |
| Akeso | 2.26B |